Development of a novel therapeutic approach for triple negative breast cancer

  • Scott, Andrew (Primary Chief Investigator (PCI))
  • Daly, Roger (Chief Investigator (CI))
  • Janes, Peter (Chief Investigator (CI))
  • Burvenich, Ingrid J.G. (Chief Investigator (CI))
  • Anderson, Robin (Chief Investigator (CI))

Project: Research

Project Details

StatusActive
Effective start/end date1/01/22 → 31/12/24